The Combined Bachelor’s/Master’s Degree program (CBM) is intended for highly motivated current CWRU undergraduate students who are candidates for any bachelor's ...
Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...
—Researchers in Finland concluded that deep cervical lymph node diameter is feasible as a biomarker for multiple sclerosis disease course. An accessible biomarker that tracks disease activity and ...
—A case-control study from Sweden examined familial risk and heritability of MS through 2 major phenotypes: relapsing onset and primary progressive. Do certain genetic effects increase the risk for ...
Multiple sclerosis (MS) is a debilitating disease with few treatment options. But in a new clinical trial, scientists have tested a promising new therapy involving injections of stem cells, which ...
Multiple sclerosis (MS) is a neurological disease that affects about 1 million people in the United States. Your brain contains a type of cell called a neuron, and neurons are coated in a layer of ...
Multiple sclerosis (MS) is characterized by a broad array of symptoms. Despite this variability, most individuals with MS will exhibit a distinct set of symptoms during their initial clinical attack.
Practicing physician and health system AI leader brings frontline and enterprise perspective to Brim Analytics' ...
Dr. Bhargava is an Associate Professor of Neurology at Johns Hopkins University School of Medicine. After obtaining his medical degree from Christian Medical College in Vellore, India, Dr. Bhargava ...
Multiple sclerosis (MS) is a chronic autoimmune neurological disease that can cause symptoms throughout the body, including vision problems, muscle weakness, balance problems, cognitive dysfunction, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback